~~<i id='8407F64C41'><strike id='8407F64C41'><tt id='8407F64C41'><pre id='8407F64C41'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

hotspot

author：leisure time 2025-10-01 21:09:51 - browse：24

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： In shift, Texas to cover initial consult for Afghan baby's gene therapy

hotspot

knowledge

explore

leisure time

explore

entertainment

AdobeRoche’sannouncementMondaythatitwouldpay$310millionforrightstoahypertensiontreatment,zilebesiran

WSS

Allen Institute goes after foundational questions, CEO Costa says

American taxpayers paid $1.8 trillion in health care costs in 2022

Russian fighter jet damages US Reaper drone with flare over Syria: Officials

How doctors’ personal politics affect patients

Life science postdocs should get big pay hike, NIH panel says

Truvian presents data for its desktop blood

explore

hotspot

hotspot

Malaria cases in Florida and Texas: Here’s what you need to know

Study suggests new cause of Down syndrome: cells linked to aging

Tori Bowie and the unacceptable rates of Black maternal death

American taxpayers paid $1.8 trillion in health care costs in 2022

Drug repurposing or repositioning? The language matters

Former reverend arrested for allegedly killing 8

At least 13 dead in Texas as scorching temps continue

Hospital chaplains balance Covid safety with patients’ spiritual needs

Peter Hotez and the public health issue of online harassment

Bronny James, LeBron's son, suffers cardiac arrest during basketball practice at USC

knowledge

Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

Biogen says it will cut costs by $700 million, slash 1,000 jobs

CDC Director Mandy Cohen on transparency, trust, and health

Truvian presents data for its desktop blood

Former reverend arrested for allegedly killing 8

explore

leisure time

explore

entertainment